Disease Overview：Bernard-Soulier syndrome（BSS）
Bernard-Soulier syndrome (BSS), also known as giant platelet syndrome, is a rare autosomal recessive bleeding disorder caused by mutations in the GP1BA, GP1BB, or GP9 genes. These defects impair the expression or function of the GPIa/IIa–GPIX complex—critical for platelet adhesion to subendothelial von Willebrand factor under high shear stress. Clinically, patients present with mucocutaneous bleeding, prolonged bleeding time, thrombocytopenia, and characteristically enlarged platelets visible on peripheral blood smear. Diagnosis relies on flow cytometry demonstrating reduced or absent CD42a (GPIa) and CD42b (GPIbα) expression, alongside genetic confirmation. Management remains supportive: avoidance of antiplatelet agents, antifibrinolytics (e.g., tranexamic acid) for minor procedures, and platelet transfusions for major hemorrhage or surgery—though alloimmunization risk limits repeated use. No curative pharmacotherapy exists; hematopoietic stem cell transplantation is considered only in severe, refractory cases.
China offers distinct advantages for international BSS patients seeking comprehensive care. Leading hematology centers—including Peking Union Medical College Hospital and Shanghai Ruijin Hospital—boast specialized coagulation disorder units with multidisciplinary expertise in inherited platelet disorders. Advanced diagnostics include next-generation sequencing panels for rapid genetic profiling and high-resolution flow cytometry. Over 30 documented successful long-term management cases demonstrate robust perioperative protocols and individualized prophylactic strategies. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical standards or regulatory oversight (NMPA-certified reagents, ISO-accredited labs). As a dedicated medical tourism agency, we facilitate seamless access: pre-arrival eligibility verification, direct coordination with designated hematologists, transparent itemized pricing (including diagnostics, consultations, and follow-up), visa support, and 24/7 bilingual patient advocacy—ensuring continuity of care from inquiry through recovery.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Bernard–Soulier Syndrome (BSS)
Non-Surgical / Conservative Management
*Target Criteria:* Mild bleeding phenotype, no major hemorrhage history, stable platelet count (>20×10⁹/L), absence of severe mucocutaneous or visceral bleeding.
- •Desmopressin (DDAVP) Infusion (IV)
- *Cost:* ¥480–¥620 per dose ($67–$86)
- •Antifibrinolytic Therapy (Tranexamic Acid)
- *Cost:* ¥95–¥130 per course ($13–$18)
- •Platelet Transfusion (Leukoreduced, ABO/Rh-matched)
- *Cost:* ¥1,850–¥2,200 per unit ($257–$306)
- •Baseline Labs & Monitoring
- Platelet function assay (PFA-100/flow cytometry for GPIa/IIa): ¥420–¥580 ($58–$81) - VWF antigen & activity: ¥360 ($50)
Surgical / Procedural Interventions
*Eligibility Criteria:* Recurrent life-threatening hemorrhage (e.g., GI, CNS), refractory menorrhagia unresponsive to medical therapy, or need for major surgery with high bleeding risk.
- •Splenectomy (Laparoscopic)
- *Procedure cost:* ¥28,500–¥36,000 ($3,960–$5,000) - *Pre-op workup:* Abdominal ultrasound + CT abdomen + immunization titers (pneumococcus/Hib/meningococcus): ¥1,950 ($271)
- •Bone Marrow Transplantation (Allogeneic, HLA-matched sibling)
- *Total cost (conditioning + transplant + 30-day inpatient):* ¥320,000–¥410,000 ($44,400–$57,000)
Special / Complex Condition Management
- •Pregnancy Management:
- Epidural anesthesia contraindicated; cesarean delivery with prophylactic platelet transfusion: +¥3,100 ($431)
- •Major Surgery (e.g., appendectomy, cholecystectomy):
Quick Selection Guide
- •Children <12 years, severe phenotype: Allogeneic BMT is first-line curative option if donor available ($44K–$57K).
- •Adults, mild-moderate bleeding, budget < $500: DDAVP + tranexamic acid + on-demand platelet transfusion ($67–$306/dose).
- •Women of childbearing age with menorrhagia: Tranexamic acid + hormonal IUD (Mirena); avoid splenectomy due to lifelong infection risk.
- •Elderly or comorbid (COPD, CAD): Conservative management only—splenectomy contraindicated; platelet transfusion reserved for active hemorrhage ($257/unit).
- •Refractory GI bleeding: Endoscopic epinephrine injection + platelet transfusion + octreotide infusion (¥1,300/day; $180/day) — not curative but bridges to definitive care.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Bernard-Soulier syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Bernard-Soulier syndrome treatment with China top medical destinations:
